LBBB: Symptoms, Causes and Treatment

How Electrical Signals Travel Through the Heart

The heart's electrical system begins at the sinoatrial node, travels through the AV node and the bundle of His, which divides into right and left bundle branches. The right branch activates the right ventricle; the left branch after subdividing into anterior and posterior fascicles, activates the left. Both normally fire within milliseconds of each other, producing the coordinated contraction that drives cardiac output.

In LBBB the left ventricle activates late through slow cell-to-cell conduction from the right ventricle. The resulting asynchronous contraction can reduce cardiac output and, over time, contribute to adverse cardiac remodelling.

What Causes LBBB?

LBBB rarely occurs in a structurally normal heart. Common causes include coronary artery disease (particularly anterior MI), hypertensive left ventricular hypertrophy, dilated cardiomyopathy, aortic valve disease and cardiac surgical or ablation procedures that damage conduction tissue.

Less commonly, LBBB occurs with myocarditis, infiltrative cardiac disease (amyloidosis, sarcoidosis) or as an isolated finding in elderly patients without identifiable structural disease. Rate-dependent LBBB, appearing only at faster heart rates, may indicate ischaemia or functional conduction limitation rather than permanent structural damage.

Types: Complete vs Incomplete LBBB

Complete LBBB is diagnosed when QRS is 120 milliseconds or wider, indicating complete conduction failure. Incomplete LBBB produces a similar but less pronounced pattern with QRS between 110 and 119 milliseconds - delayed but not fully interrupted. Complete LBBB has significantly greater haemodynamic implications particularly in heart failure.

Symptoms of LBBB 

Many patients have no symptoms as the condition is discovered incidentally on a routine ECG. Symptomatic LBBB reflects the underlying cardiac condition rather than the conduction block itself. Common symptoms include breathlessness on exertion, fatigue, reduced exercise tolerance, palpitations, and dizziness.

Chest pain in a patient with known LBBB requires emergency assessment as LBBB produces ST changes that can mask acute myocardial infarction per the Sgarbossa criteria. New or worsening chest pain in this setting should not be observed at home.

Who Is at Risk?

Certain people are more susceptible to LBBB. They are:

• Adults over 50 with long-standing hypertension or coronary artery disease

• Those with cardiomyopathy or valvular heart disease

• Prior myocardial infarction (especially anterior MI) which can damage left bundle branch tissue directly

• Diabetes accelerates coronary atherosclerosis and may affect cardiac conduction tissue

• Prior cardiac surgery or catheter ablation near the conduction system

How LBBB Looks on an ECG

Complete LBBB on ECG shows a QRS of 120 milliseconds or wider, broad notched R waves in the lateral leads (I, aVL, V5, V6), absent Q waves in those leads and a wide negative QS complex in V1. Secondary ST depression and T wave inversion in the lateral leads reflect abnormal repolarisation, not independent ischaemia.

Distinguishing ischaemic ST changes from LBBB-related changes requires clinical correlation, serial ECGs and troponin measurement. New LBBB during chest pain is treated as a STEMI equivalent in most protocols, warranting emergency coronary angiography.

Is LBBB Always a Sign of Heart Disease?

No but it usually is. Eriksson et al. found that new LBBB in men significantly increased mortality risk. A small proportion of patients (particularly older individuals) may have LBBB without identifiable structural disease after comprehensive evaluation, requiring monitoring rather than immediate intervention.

How Is LBBB Diagnosed?

LBBB is an ECG diagnosis. Echocardiography follows, assessing left ventricular size, ejection fraction, wall motion, valve structure and dyssynchrony. Stress testing identifies rate-dependent LBBB and assesses for underlying coronary disease.

Cardiac MRI characterises myocardial tissue - identifying scar, inflammation or infiltrative disease. Coronary angiography assesses coronary anatomy where obstructive disease is suspected. Troponin, BNP or NT-proBNP and thyroid function complete the initial workup.

Treatment Options for LBBB

LBBB has no specific pharmacological treatment and the management targets the underlying cause:

• Coronary disease is addressed with revascularisation and risk factor modification. 

• Heart failure is managed with ACE inhibitors or ARBs, beta-blockers, and SGLT2 inhibitors.

• For patients with LBBB and ejection fraction at or below 35%, cardiac resynchronisation therapy (CRT) which may include a biventricular pacemaker with leads to both ventricles can restore simultaneous activation and dramatically improve cardiac output and symptoms. 

• LBBB with QRS above 150 milliseconds is the strongest predictor of CRT response. ICDs are combined with CRT (CRT-D) in patients at high sudden death risk.

LBBB and Risk of Heart Failure – What the Research Says

LBBB is independently associated with incident heart failure and all-cause mortality. The abnormal activation sequence produces regional wall stress differences leading over time to left ventricular dilation and worsening systolic function. The CARE-HF and COMPANION trials demonstrated that CRT reduces mortality, hospitalisations and improves quality of life in LBBB-associated heart failure.

Living With LBBB – What to Monitor

Doctors schedule your appointments to monitor:

• Regular echocardiography - annually or when symptoms change to track left ventricular size and ejection fraction

• Blood pressure control - hypertension accelerates underlying heart disease progression and dyssynchrony-mediated remodelling

• Symptom awareness - new or worsening breathlessness, oedema or exercise intolerance should prompt cardiac review

• Medication adherence - consistent use of heart failure therapy is directly associated with outcomes

• Avoid conduction-suppressing drugs - class I antiarrhythmics can worsen LBBB or precipitate complete heart block.

Questions to Ask Your Cardiologist

You should ask these questions in your scheduled appointments:

• What is my ejection fraction, and does it meet CRT criteria?

• Do I need stress testing or coronary angiography to evaluate the cause?

• Which symptoms should prompt emergency care and what monitoring schedule suits my case?

Conclusion

LBBB ranges from an incidental finding requiring monitoring to a marker of serious cardiac disease requiring aggressive treatment. Its presence mandates cardiac evaluation to identify or exclude structural disease. Where dyssynchrony has produced heart failure with reduced ejection fraction, CRT offers one of cardiology's most dramatic treatment benefits. New chest pain in a patient with known LBBB always requires emergency evaluation

FAQs

1. Is LBBB a serious or life-threatening condition?

LBBB with preserved ejection fraction and no underlying disease has a relatively benign prognosis. LBBB with reduced ejection fraction, heart failure or coronary disease carries significantly elevated risk. New LBBB during chest pain is a cardiac emergency.

2. Can LBBB go away on its own?

Permanent LBBB from myocardial infarction or structural disease does not resolve. Rate dependent LBBB disappears at rest and is not permanent. Reversible causes like myocarditis or electrolyte disturbance produce transient LBBB that resolves with treatment.

3. What does it feel like to have LBBB?

Many people feel nothing and LBBB is frequently an incidental ECG finding. When symptoms occur, they reflect the underlying condition: breathlessness, fatigue, reduced exercise tolerance or palpitations. Symptoms attributable to the block alone are uncommon.

4. Is LBBB the same as a heart block?

No. Heart block refers to a block at the AV node level. LBBB refers to block in the bundle branch system below the AV node. Both affect the conduction system but at different anatomical levels and with different clinical implications.

5. Can LBBB be detected without an ECG?

The ECG is the only practical diagnostic tool. Physical examination may reveal a paradoxically split second heart sound - associated with delayed left ventricular activation but ECG confirmation is required.

6. Does LBBB always require a pacemaker?

No. Most patients with LBBB do not require a pacemaker. CRT is indicated when LBBB is accompanied by an ejection fraction at or below 35% and heart failure symptoms despite optimal medical therapy and not when ejection fraction is preserved.

7. Can LBBB develop without any underlying heart disease?

Occasionally, particularly in older adults. Idiopathic LBBB (without identifiable structural disease) is uncommon but recognised. These patients require ongoing monitoring as LBBB is associated with incident cardiac disease even when initial evaluation is negative.

8. What lifestyle changes are recommended for someone with LBBB?

Blood pressure control is the most important modifiable factor. Smoking cessation, a heart-healthy diet (dal, ragi, jowar, leafy vegetables), regular moderate-intensity exercise and weight management reduce the progression of underlying cardiac disease driving LBBB.

9. Can LBBB affect your ability to exercise?

LBBB with preserved ejection fraction does not typically limit exercise capacity. When associated with heart failure or reduced ejection fraction, exercise capacity is impaired by the cardiac dysfunction. A supervised stress test characterises functional capacity and guides exercise prescription.

10. Is LBBB more common in men or women?

LBBB is more prevalent in men, reflecting higher rates of coronary artery disease, hypertension and left ventricular hypertrophy in the male population. Prevalence increases with age in both sexes.

11. Can LBBB cause chest pain?

LBBB itself does not cause chest pain. It frequently coexists with coronary artery disease, which does. New or worsening chest pain in a patient with known LBBB requires emergency assessment as LBBB can mask the ECG changes of acute MI, making troponin measurement particularly important.

References

1. Eriksson P, Hansson PO, Eriksson H, Dellborg M. Bundle-branch block in a general male population: the study of men born 1913. Circulation. 1998;98(22):2494–2500. https://doi.org/10.1161/01.CIR.98.22.2494

2. Cleland JG, Daubert JC, Erdmann E, et al; CARE-HF Study Investigators. The effect of cardiac resynchronisation on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–49. https://doi.org/10.1056/NEJMoa050496

3. Bristow MR, Saxon LA, Boehmer J, et al; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronisation therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140–50. https://doi.org/10.1056/NEJMoa032423

4. Sgarbossa EB, Pinski SL, Barbagelata A, et al. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. N Engl J Med. 1996;334(8):481–7. https://doi.org/10.1056/NEJM199602223340801

5. McDonagh TA, Metra M, Adamo M, et al; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726. https://doi.org/10.1093/eurheartj/ehab368